Janine de Carvalho Bonfadini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Janine de Carvalho Bonfadini has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Pedro Braga-Neto
Clinical Medicine, Universidade Federal do Ceara, Rua Professor Costa Mendes 1608, 4th floor, Rodolfo Teofilo, Fortaleza, CE, 60430-140, Brazil
5 shared publications - Danielle Pessoa Lima
Universidade Federal do Ceará
4 shared publications - Samuel Brito de Almeida
Universidade Federal do Ceará, Hospital Univerisátio Walter Cantídio, Unidade de Pesquisa Clínica, Fortaleza CE, Brazil
4 shared publications - Alexandre Henrique Silva Carneiro
Universidade Federal do Ceará, Brazil
3 shared publications - Ana Cecília Nogueira e Silva
Universidade Federal do Ceará (UFC), Fortaleza, Ceará, Brasil
2 shared publications - Antonio Brazil Viana Júnior
Universidade Federal do Ceará
2 shared publications
Latest Publications
- Open Access
- 5 September 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93340
Desafios na educação em saúde na doença de Parkinson: construção e validação de um manual para pacientes
Objetivo: Desenvolver e validar material educativo destinado às pessoas com doença de Parkinson para facilitar o entendimento sobre a doença, incluindo quadro clínico, tratamento e terapêutica não farmacológica. Metodologia: Estudo metodológico com abordagem quantitativa e qualitativa desenvolvido em três etapas: construção do manual, validação por especialistas e validação pelo público-alvo. O manual “Viver com Parkinson” aborda os sintomas, o tratamento, as complicações e as estratégias de enfrentamento da doença de Parkinson. Resultados: O material obteve nível de concordância de 90,93% pelo julgamento dos especialistas e de 98,66% pelo público-alvo, sendo classificado com conceituação máxima por ambos os grupos. Os pacientes consideraram o manual informativo, explicativo e motivador para ações de autocuidado. Conclusão: O manual se mostrou válido quanto ao conteúdo e à aparência segundo especialistas e pacientes com doença de Parkinson, com potencial para promover mudanças adaptativas de autocuidado.
- 5 September 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93340
Open AccessDesafios na educação em saúde na doença de Parkinson: construção e validação de um manual para pacientes
Objetivo: Desenvolver e validar material educativo destinado às pessoas com doença de Parkinson para facilitar o entendimento sobre a doença, incluindo quadro clínico, tratamento e terapêutica não farmacológica. Metodologia: Estudo metodológico com abordagem quantitativa e qualitativa desenvolvido em três etapas: construção do manual, validação por especialistas e validação pelo público-alvo. O manual “Viver com Parkinson” aborda os sintomas, o tratamento, as complicações e as estratégias de enfrentamento da doença de Parkinson. Resultados: O material obteve nível de concordância de 90,93% pelo julgamento dos especialistas e de 98,66% pelo público-alvo, sendo classificado com conceituação máxima por ambos os grupos. Os pacientes consideraram o manual informativo, explicativo e motivador para ações de autocuidado. Conclusão: O manual se mostrou válido quanto ao conteúdo e à aparência segundo especialistas e pacientes com doença de Parkinson, com potencial para promover mudanças adaptativas de autocuidado.
- Open Access
- 29 August 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93149
PARK-BAND training program for Parkinson’s disease: a feasibility study
Objective: The purpose of this study was to identify primary endpoints related to feasibility of power training in patients with mild-to-moderate Parkinson Disease (PD). Methods: This is a pilot study of a randomized controlled trial blinded for data analyzers and outcome evaluators, lasting 12 weeks. We aim to compare power training to a health education program. The pre-planned primary endpoints of the Randomized Clinical Trial are the bradykinesia scores of the Unified Parkinson Disease Rating Scale (UPDRS) and Short Physical Performance Battery (SPPB). Participants were randomized to two groups: power training group (PTG) and health education group (HEG) in 1:1 ratio through a permuted block of 8 patients. Results: A total of 34 patients were screened and 8 were enrolled and randomized. Five (62.5%) were female and the median age was 66 (45–77) years. Attendance rate to HEG was 83.3% and to PTG 96.82%, adherence rate to HEG was 80% and to PTG 95.23%, retention rate was 75%. No adverse events were related to the intervention. Conclusions: PARK-BAND Training Program for Parkinson’s Disease: A Feasibility Study (PARK-BAND) pilot had reasonable acceptance, attendance, adherence, and safety rates to start. (REBEC number: RBR-5w2sq).
- 29 August 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93149
Open AccessPARK-BAND training program for Parkinson’s disease: a feasibility study
Objective: The purpose of this study was to identify primary endpoints related to feasibility of power training in patients with mild-to-moderate Parkinson Disease (PD). Methods: This is a pilot study of a randomized controlled trial blinded for data analyzers and outcome evaluators, lasting 12 weeks. We aim to compare power training to a health education program. The pre-planned primary endpoints of the Randomized Clinical Trial are the bradykinesia scores of the Unified Parkinson Disease Rating Scale (UPDRS) and Short Physical Performance Battery (SPPB). Participants were randomized to two groups: power training group (PTG) and health education group (HEG) in 1:1 ratio through a permuted block of 8 patients. Results: A total of 34 patients were screened and 8 were enrolled and randomized. Five (62.5%) were female and the median age was 66 (45–77) years. Attendance rate to HEG was 83.3% and to PTG 96.82%, adherence rate to HEG was 80% and to PTG 95.23%, retention rate was 75%. No adverse events were related to the intervention. Conclusions: PARK-BAND Training Program for Parkinson’s Disease: A Feasibility Study (PARK-BAND) pilot had reasonable acceptance, attendance, adherence, and safety rates to start. (REBEC number: RBR-5w2sq).
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 17, e20220084
Educational disparities in Brazil may interfere with the cognitive performance of Parkinson's disease patients
The prevalence of cognitive impairment in Parkinson's disease (PD) is about 20% to 60%. The Mini-Mental Status Examination (MMSE) is the most used cognitive screening test. Objective: To evaluate the influence of clinical and demographic characteristics, specifically the education level, on the MMSE score in PD patients of a northeast Brazilian sample. Methods: We performed a cross-sectional study of 198 PD patients at a Movement Disorders outpatient clinic in Fortaleza, CE, Brazil. Participants were assessed by detailed clinical history, modified Hoehn and Yahr staging (HY), geriatric depression scale (GDS) and MMSE. Results: We found that 68% of patients had MMSE scores below the Brazilian thresholds, which were based in Brucki et al. study (2003). There was a statistically significant difference in the bivariate analysis between educational level and cut-off classification for MMSE. More years of formal schooling were associated with more patients scoring below threshold. We found that 75%, 68.8%, and 79.7% of individuals with more than 11, 9 to 11, and 4 to 8 years of formal schooling, respectively, were below the suggested Brazilian Brucki's threshold. GDS and age were negatively correlated with total MMSE and all its domains. There was no correlation between disease duration and MMSE. Subjects with hallucinations had lower scores. Conclusion: Most of the sample had lower performance according to Brazilian thresholds, but there was no control group and no neuropsychological test in this study. Further studies in northeast Brazil are needed to review MMSE cut-off values.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 17, e20220084
Open AccessEducational disparities in Brazil may interfere with the cognitive performance of Parkinson's disease patients
The prevalence of cognitive impairment in Parkinson's disease (PD) is about 20% to 60%. The Mini-Mental Status Examination (MMSE) is the most used cognitive screening test. Objective: To evaluate the influence of clinical and demographic characteristics, specifically the education level, on the MMSE score in PD patients of a northeast Brazilian sample. Methods: We performed a cross-sectional study of 198 PD patients at a Movement Disorders outpatient clinic in Fortaleza, CE, Brazil. Participants were assessed by detailed clinical history, modified Hoehn and Yahr staging (HY), geriatric depression scale (GDS) and MMSE. Results: We found that 68% of patients had MMSE scores below the Brazilian thresholds, which were based in Brucki et al. study (2003). There was a statistically significant difference in the bivariate analysis between educational level and cut-off classification for MMSE. More years of formal schooling were associated with more patients scoring below threshold. We found that 75%, 68.8%, and 79.7% of individuals with more than 11, 9 to 11, and 4 to 8 years of formal schooling, respectively, were below the suggested Brazilian Brucki's threshold. GDS and age were negatively correlated with total MMSE and all its domains. There was no correlation between disease duration and MMSE. Subjects with hallucinations had lower scores. Conclusion: Most of the sample had lower performance according to Brazilian thresholds, but there was no control group and no neuropsychological test in this study. Further studies in northeast Brazil are needed to review MMSE cut-off values.
- Open Access
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 16 (2) , 153-161
Falls in Parkinson's disease: the impact of disease progression, treatment, and motor complications
The prevalence of Parkinson's disease (PD) tends to increase worldwide in the coming decades. Thus, the incidence of falls is likely to increase, with a relevant burden on the health care system. Objective: The objective of this study was to evaluate clinical factors and drug use associated with falls in PD patients. Methods: We conducted a cross-sectional study at the Movement Disorders outpatient clinic of a tertiary hospital in Northeast Brazil. We performed structured interviews to collect sociodemographic and clinical data. Functional capacity was assessed using the Schwab and England Activities of Daily Living Scale and the modified Hoehn and Yahr Staging Scale. We divided the study sample into non-fallers (no falls) and fallers (≥1 fall), and non-recurrent (≤1 fall) and recurrent fallers (>1 fall). Results: The study population comprised 327 PD patients (48% women), with a mean age of 70 years. The mean disease duration was 9.9±6.9 years. The most prevalent comorbidities were depression (47.2%), hypertension (44.0%), and type 2 diabetes mellitus (21.5%). The logistic regression analysis revealed that hallucinations, amantadine, and catechol-O-methyltransferase inhibitors (entacapone) were independently associated with falls in PD patients. Also, hallucinations, dyskinesia, and the use of amantadine were independently associated with recurrent falls. Conclusions: Health care providers play an essential role in fall prevention in PD patients, particularly by identifying older adults experiencing dyskinesia and visual hallucinations. Prospective studies should investigate the use of amantadine as a risk factor for falls in PD patients.
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 16 (2) , 153-161
Open AccessFalls in Parkinson's disease: the impact of disease progression, treatment, and motor complications
The prevalence of Parkinson's disease (PD) tends to increase worldwide in the coming decades. Thus, the incidence of falls is likely to increase, with a relevant burden on the health care system. Objective: The objective of this study was to evaluate clinical factors and drug use associated with falls in PD patients. Methods: We conducted a cross-sectional study at the Movement Disorders outpatient clinic of a tertiary hospital in Northeast Brazil. We performed structured interviews to collect sociodemographic and clinical data. Functional capacity was assessed using the Schwab and England Activities of Daily Living Scale and the modified Hoehn and Yahr Staging Scale. We divided the study sample into non-fallers (no falls) and fallers (≥1 fall), and non-recurrent (≤1 fall) and recurrent fallers (>1 fall). Results: The study population comprised 327 PD patients (48% women), with a mean age of 70 years. The mean disease duration was 9.9±6.9 years. The most prevalent comorbidities were depression (47.2%), hypertension (44.0%), and type 2 diabetes mellitus (21.5%). The logistic regression analysis revealed that hallucinations, amantadine, and catechol-O-methyltransferase inhibitors (entacapone) were independently associated with falls in PD patients. Also, hallucinations, dyskinesia, and the use of amantadine were independently associated with recurrent falls. Conclusions: Health care providers play an essential role in fall prevention in PD patients, particularly by identifying older adults experiencing dyskinesia and visual hallucinations. Prospective studies should investigate the use of amantadine as a risk factor for falls in PD patients.
- Open Access
- 1 March 2021
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Psiquiatria
- Vol. 70 (1) , 45-53
Clinical characteristics and diagnostic accuracy of the revised Addenbrooke Cognitive Examination (ACE-R) in older adults with a low educational level
Objective: To determine the diagnostic accuracy of the Addenbrooke’s Cognitive Examination Revised (ACE-R) as a cognitive screening tool for older adults with low levels of schooling and healthy aging, MCI and dementia in Brazil. Methods: All participants underwent neurological and psychiatric examinations and were administered a validated version of ACE-R. Results: A total of 85 participants were evaluated; most were females (84.7%, n = 72). The post hoc analysis showed statistical differences in ACE-R total scores between older adults with mild cognitive impairment (MCI) and controls (p < 0.001) and in subitem scores including verbal fluency, language, visuospatial skills and attention (p < 0.001). The visual-spatial skills subitem was the most strongly correlated with schooling level (r = 0.509, p < 0.001), whereas late, immediate recall and recognition memory were not influenced by schooling. The ACE-R had the best diagnostic accuracy in discriminating between MCI and controls = 0.69 (<57.5; 80/66), MD and controls = 0.98 (<50; 100/96), MCI and MD = 0.86 (<49.5; 100/74). Conclusions: ACE-R and Mini-Mental State Examination (MMSE) scores for older adults with MCI and controls were significantly lower than those reported in similar studies. These preliminary findings support the need for establishing reliable cut-off scores for cognitive assessment of older Brazilian adults with low schooling at risk for dementia taking into consideration ecological and local variables.
- 1 March 2021
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Psiquiatria
- Vol. 70 (1) , 45-53
Open AccessClinical characteristics and diagnostic accuracy of the revised Addenbrooke Cognitive Examination (ACE-R) in older adults with a low educational level
Objective: To determine the diagnostic accuracy of the Addenbrooke’s Cognitive Examination Revised (ACE-R) as a cognitive screening tool for older adults with low levels of schooling and healthy aging, MCI and dementia in Brazil. Methods: All participants underwent neurological and psychiatric examinations and were administered a validated version of ACE-R. Results: A total of 85 participants were evaluated; most were females (84.7%, n = 72). The post hoc analysis showed statistical differences in ACE-R total scores between older adults with mild cognitive impairment (MCI) and controls (p < 0.001) and in subitem scores including verbal fluency, language, visuospatial skills and attention (p < 0.001). The visual-spatial skills subitem was the most strongly correlated with schooling level (r = 0.509, p < 0.001), whereas late, immediate recall and recognition memory were not influenced by schooling. The ACE-R had the best diagnostic accuracy in discriminating between MCI and controls = 0.69 (<57.5; 80/66), MD and controls = 0.98 (<50; 100/96), MCI and MD = 0.86 (<49.5; 100/74). Conclusions: ACE-R and Mini-Mental State Examination (MMSE) scores for older adults with MCI and controls were significantly lower than those reported in similar studies. These preliminary findings support the need for establishing reliable cut-off scores for cognitive assessment of older Brazilian adults with low schooling at risk for dementia taking into consideration ecological and local variables.